Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The primary objective is to evaluate the experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy at the Centre Hospitalier Régional et Universitaire of Lille
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
O has malignant haemopathy O follow-up in the pediatric hematology department in Lille, O diagnosed from 6 weeks to 1 year before maintenance of the healthy subject included
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
7 participants in 1 patient group
Loading...
Central trial contact
Eva De Berranger, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal